Medicare program spent $1.8 billion in 2019 on drugs without confirmed clinical benefits

The U.S. federal government spent an estimated $1.8 billion in Medicare funds in 2019 on drugs whose clinical benefits have yet to be confirmed by the Food and Drug Administration, a new study led by researchers from the Johns Hopkins Bloomberg School of Public Health suggests.

from Breaking World Pharma News https://ift.tt/F2Kj4Je